Patents Assigned to RIVOPHARM SA
  • Patent number: 10188607
    Abstract: The object of the present invention is a pharmaceutical formulation of racecadotril characterized by high bioavailability. In particular, the present invention relates to a method of dry granulating racecadotril in the presence of a hydrophilic excipient and a disintegrant, preferably with a low moisture content; said method being carried out by means of a tablet machine or alternately a roller compacting machine, carrying out the compaction step with a compaction strength of less than 30 kN and equal to or greater than 4 kN, and the step of grinding the slugs and screening so as to obtain a granulate in which not more than 50% by weight of the product has a particle size of less than 90 micron.
    Type: Grant
    Filed: December 23, 2015
    Date of Patent: January 29, 2019
    Assignee: Rivopharm SA
    Inventors: Piero Poli, Alessandro Fiorino, Tommaso Roberto Piazzolla
  • Publication number: 20180028448
    Abstract: The object of the present invention is a pharmaceutical formulation of racecadotril characterized by high bioavailability. In particular, the present invention relates to a method of dry granulating racecadotril in the presence of a hydrophilic excipient and a disintegrant, preferably with a low moisture content; said method being carried out by means of a tablet machine or alternately a roller compacting machine, carrying out the compaction step with a compaction strength of less than 30 kN and equal to or greater than 4 kN, and the step of grinding the slugs and screening so as to obtain a granulate in which not more than 50% by weight of the product has a particle size of less than 90 micron.
    Type: Application
    Filed: December 23, 2015
    Publication date: February 1, 2018
    Applicant: Rivopharm SA
    Inventors: Piero Poli, Alessandro Fiorino, Tommaso Roberto Piazzolla
  • Publication number: 20150190388
    Abstract: The subject of the present invention is a method for preparing a pharmaceutical moxifloxacin hydrochloride composition in solid form, which comprises mixing a moxifloxacin hydrochloride having a water content of less than 2% by weight with one or more pharmaceutically acceptable excipients. The subject of the invention is also a pharmaceutical composition obtainable by this method.
    Type: Application
    Filed: June 21, 2013
    Publication date: July 9, 2015
    Applicant: RIVOPHARM SA
    Inventors: Piero Poli, Michela Carcano, Gabriele Vecchi
  • Publication number: 20110002987
    Abstract: The invention provides a carrier for nicorandil, which is preferably in form of a blister pack, comprising one or several dose blister pockets each containing at least one tablet of nicorandil, and at least one blister pocket containing a molecular sieve.
    Type: Application
    Filed: March 4, 2009
    Publication date: January 6, 2011
    Applicant: RIVOPHARM SA
    Inventors: Piero Poli, Michela Carcano